{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:06:20Z","timestamp":1792638380813,"version":"4.5.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ejpn-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Paediatric Neurology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.ejpn.2015.12.013","type":"journal-article","created":{"date-parts":[[2016,1,8]],"date-time":"2016-01-08T12:17:07Z","timestamp":1452255427000},"page":"212-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Clinical experience of intravenous lacosamide in infants and young children"],"prefix":"10.1016","volume":"20","author":[{"given":"Dimitrios","family":"Arkilo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Gustafson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpn.2015.12.013_bib1","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/jnr.23136","article-title":"Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivation","volume":"91","author":"Niespodziany","year":"2013","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.ejpn.2015.12.013_bib2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/11636260-000000000-00000","article-title":"Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain","volume":"12","author":"Casas-Fern\u00e1ndez","year":"2012","journal-title":"Drugs R D"},{"issue":"4","key":"10.1016\/j.ejpn.2015.12.013_bib3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.pediatrneurol.2014.07.004","article-title":"Efficacy and tolerability of lacosamide as an adjunctive therapy in children with refractory partial epilepsy","volume":"51","author":"Pasha","year":"2014","journal-title":"Pediatr Neurol"},{"issue":"1","key":"10.1016\/j.ejpn.2015.12.013_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejpn.2011.08.007","article-title":"Preliminary efficacy and safety of lacosamide in children with refractory epilepsy","volume":"16","author":"Heyman","year":"2012","journal-title":"Eur J Paediatr Neurol"},{"issue":"1","key":"10.1016\/j.ejpn.2015.12.013_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.seizure.2012.10.004","article-title":"Efficacy of intravenous lacosamide as an add-on treatment in refractory status epilepticus: a multicenter prospective study","volume":"22","author":"Miro","year":"2013","journal-title":"Seizure"},{"issue":"5","key":"10.1016\/j.ejpn.2015.12.013_bib6","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/ane.12174","article-title":"Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus","volume":"129","author":"Kellinghaus","year":"2014","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"10.1016\/j.ejpn.2015.12.013_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5698\/1535-7597-13.5.217","article-title":"Treatment of super-refractory status epilepticus: the sooner the better with less adverse effects","volume":"13","author":"Buchhalter","year":"2013","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.ejpn.2015.12.013_bib8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.spen.2010.10.003","article-title":"New drugs for pediatric epilepsy","volume":"17","author":"Chu-Shore","year":"2010","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.ejpn.2015.12.013_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/1756285609355850","article-title":"New treatment option for partial-onset seizures: efficacy and safety of lacosamide","volume":"3","author":"Chung","year":"2010","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"10.1016\/j.ejpn.2015.12.013_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejpn.2013.08.006","article-title":"Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy","volume":"18","author":"Grosso","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ejpn.2015.12.013_bib11","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.ejpn.2014.04.013","article-title":"Lacosamide in children with refractory status epilepticus. A multicenter Italian experience","volume":"18","author":"Grosso","year":"2014","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.ejpn.2015.12.013_bib12","unstructured":"Smyrna, GA: UCB, Inc.; February 2012. Vimpat [package insert] http:\/\/www.vimpat.com [accessed 15.09.12]."},{"issue":"4","key":"10.1016\/j.ejpn.2015.12.013_bib13","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.yebeh.2011.02.006","article-title":"Atrioventicular block following lacosamide intoxication","volume":"20","author":"Krause","year":"2011","journal-title":"Epilepsy Behav"},{"issue":"10","key":"10.1016\/j.ejpn.2015.12.013_bib14","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1111\/j.1528-1167.2011.03212.x","article-title":"Lacosamide-induced second degree atrioventricular block in a patient with partial epilepsy","volume":"52","author":"Nizam","year":"2011","journal-title":"Epilepsia"}],"container-title":["European Journal of Paediatric Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379816000027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090379816000027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T04:52:59Z","timestamp":1537073579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090379816000027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S1090379816000027"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpn.2015.12.013","relation":{},"ISSN":["1090-3798"],"issn-type":[{"value":"1090-3798","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical experience of intravenous lacosamide in infants and young children","name":"articletitle","label":"Article Title"},{"value":"European Journal of Paediatric Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpn.2015.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}